Fibrocell to Host Conference Call and Webcast on Monday, November 13, 2017 to Discuss Third Quarter 2017 Financial Results an...
November 06 2017 - 8:00AM
Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company
focused on transformational autologous cell-based therapies for
skin and connective tissue diseases, will report financial results
for the third quarter ended September 30, 2017 and recent
operational highlights on Monday, November 13, 2017, before the
open of the U.S. financial markets. Fibrocell will also host
a conference call and webcast at 8:30 a.m. EST on the same day to
discuss its financial results and operational highlights. A
question-and-answer session will follow Fibrocell’s remarks.
To participate on the live call, please dial
866-548-4713 (domestic) or +1-323-794-2093 (international), and
provide the conference code 9063692 five to ten minutes before the
start of the call. The conference call will also be webcast live
under the investor relations section of Fibrocell's website at
www.fibrocell.com/investors/events and will be archived there for
30 days following the call.
About Fibrocell
Fibrocell is an autologous cell and gene therapy
company translating personalized biologics into medical
breakthroughs for diseases affecting the skin and connective
tissue. Fibrocell’s most advanced product candidate, FCX-007,
is the subject of a Phase 1/2 clinical trial for the treatment of
recessive dystrophic epidermolysis bullosa (RDEB). Fibrocell
is in pre-clinical development of FCX-013, its product candidate
for the treatment of moderate to severe localized
scleroderma. Fibrocell’s gene therapy portfolio is being
developed in collaboration with Intrexon Corporation (NYSE:XON), a
leader in synthetic biology. For more information, visit
www.fibrocell.com or follow Fibrocell on Twitter at @Fibrocell.
Trademarks
Fibrocell, the Fibrocell logo, and Fibrocell
Science are trademarks of Fibrocell Science, Inc. and/or its
affiliates. All other names may be trademarks of their
respective owners.
Investor & Media Relations Contact:Karen
Casey484-713-6133kcasey@fibrocell.com
Fibrocell Science (NASDAQ:FCSC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fibrocell Science (NASDAQ:FCSC)
Historical Stock Chart
From Jul 2023 to Jul 2024